Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose cytarabine

This publication has 22 references indexed in Scilit:

• Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous Leukemia
  Annals of Internal Medicine, 1991
• Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome
  Science, 1990
• The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias
  New England Journal of Medicine, 1988
• In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.
  Proceedings of the National Academy of Sciences, 1987
• Preferential inhibition by cytarabine of CFU-GM from patients with chronic granulocytic leukemia
  Cancer, 1987
• Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon Alpha_Ain Chronic Myelogenous Leukemia
  New England Journal of Medicine, 1986
• Evidence of a New Chimericbcr/c-ablmRNA in Patients with Chronic Myelocytic Leukemia and the Philadelphia Chromosome
  New England Journal of Medicine, 1985
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
  Nature, 1985
• An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity
  Cell, 1984
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
  Nature, 1973